Anika Therapeutics (ANIK) Other Operating Expenses (2010 - 2021)

Anika Therapeutics (ANIK) has 12 years of Other Operating Expenses data on file, last reported at $825000.0 in Q4 2021.

• Other Operating Expenses for Q4 2021 came in at $825000.0, up 105.27% year-over-year; the trailing twelve-month figure through Sep 2022 was $825000.0 (up 108.47% YoY), and the FY2021 annual result was -$21.1 million, up 8.22% from the prior year.
• Other Operating Expenses rose to $825000.0 in Q4 2021 per ANIK's latest filing, from -$3.4 million in the prior quarter.
• Over five years, Other Operating Expenses peaked at $8.7 million in Q4 2017 and troughed at -$24.3 million in Q4 2018.
• A 5-year average of $1.0 million and a median of $5.0 million in 2019 frame the typical range for Other Operating Expenses.
• On a YoY basis, Other Operating Expenses climbed as much as 30763.64% in 2020 and fell as far as 10200.0% in 2020.
• A 5-year view of Other Operating Expenses shows it stood at $8.7 million in 2017, then plunged by 378.56% to -$24.3 million in 2018, then surged by 99.37% to -$152000.0 in 2019, then plunged by 10200.0% to -$15.7 million in 2020, then jumped by 105.27% to $825000.0 in 2021.
• Business Quant data shows ANIK's Other Operating Expenses at $825000.0 in Q4 2021, -$3.4 million in Q3 2021, and $6.5 million in Q2 2021.